ELV Elevance Health Inc
- Stocks
- Healthcare
- NYSE: ELV
Price (delayed)
$274.93
Market cap
$61.91B
P/E Ratio
11.63
Dividend/share
$6.68
EPS
$23.63
Enterprise value
$83.53B
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately
Highlights
ELV's P/E is 35% below its 5-year quarterly average of 17.9 and 30% below its last 4 quarters average of 16.6
The company's revenue rose by 10% YoY and by 3.2% QoQ
Elevance Health's net income has decreased by 20% YoY and by 9% QoQ
Elevance Health's EPS has decreased by 18% YoY and by 8% QoQ
Key stats
What are the main financial stats of ELV
Market
Valuations
Earnings
Shares outstanding
225.18M
Market cap
$61.91B
Enterprise value
$83.53B
Price to earnings (P/E)
11.63
Price to book (P/B)
1.42
Price to sales (P/S)
0.33
EV/EBIT
9.94
EV/EBITDA
8.45
EV/Sales
0.44
Revenue
$189.22B
Gross profit
$29.37B
Operating income
$8.39B
Net income
$5.36B
EBIT
$8.4B
EBITDA
$9.88B
Free cash flow
$5.34B
Per share
Balance sheet
Liquidity
EPS
$23.63
EPS diluted
$23.56
Free cash flow per share
$23.62
Book value per share
$193.52
Revenue per share
$837.48
TBVPS
$363.29
Total assets
$121.94B
Total liabilities
$78.09B
Debt
$30.19B
Equity
$43.72B
Working capital
$19.49B
Debt to equity
0.69
Current ratio
1.44
Quick ratio
1.32
Net debt/EBITDA
2.19
Margins
Efficiency
Dividend
EBITDA margin
5.2%
Gross margin
15.5%
Net margin
2.8%
Operating margin
4.4%
Return on assets
4.5%
Return on equity
12.5%
Return on invested capital
14.3%
Return on capital employed
10.8%
Return on sales
4.4%
Dividend yield
2.43%
DPS
$6.68
Payout ratio
28.3%
ELV stock price
How has the Elevance Health stock price performed over time
Intraday
0.1%
1 week
-3.86%
1 month
-20.96%
1 year
-48.63%
YTD
-25.47%
QTD
-29.32%
Financial performance
How have Elevance Health's revenue and profit performed over time
Revenue
$189.22B
Gross profit
$29.37B
Operating income
$8.39B
Net income
$5.36B
Gross margin
15.5%
Net margin
2.8%
Elevance Health's net margin has decreased by 28% YoY and by 13% from the previous quarter
The operating margin has declined by 21% year-on-year and by 10% since the previous quarter
Elevance Health's net income has decreased by 20% YoY and by 9% QoQ
ELV's gross margin is down by 13% year-on-year and by 5% since the previous quarter
Price vs fundamentals
How does ELV's price correlate with its fundamentals
Growth
What is Elevance Health's growth rate over time
Valuation
What is Elevance Health stock price valuation
P/E
11.63
P/B
1.42
P/S
0.33
EV/EBIT
9.94
EV/EBITDA
8.45
EV/Sales
0.44
ELV's P/E is 35% below its 5-year quarterly average of 17.9 and 30% below its last 4 quarters average of 16.6
Elevance Health's EPS has decreased by 18% YoY and by 8% QoQ
ELV's price to book (P/B) is 47% lower than its 5-year quarterly average of 2.7 and 38% lower than its last 4 quarters average of 2.3
The equity has increased by 3.6% YoY and by 2.9% from the previous quarter
ELV's P/S is 53% below its 5-year quarterly average of 0.7 and 34% below its last 4 quarters average of 0.5
The company's revenue rose by 10% YoY and by 3.2% QoQ
Efficiency
How efficient is Elevance Health business performance
ELV's ROE is down by 25% YoY and by 10% QoQ
Elevance Health's return on assets has decreased by 25% YoY and by 12% QoQ
Elevance Health's ROIC has decreased by 25% YoY and by 8% from the previous quarter
Elevance Health's return on sales has decreased by 21% YoY and by 10% QoQ
Dividends
What is ELV's dividend history
DPS
$6.68
Dividend yield
2.43%
Payout ratio
28.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Elevance Health financials performed over time
The total assets is 56% higher than the total liabilities
The total liabilities is up by 10% year-on-year
The total assets rose by 8% YoY
Elevance Health's debt is 31% less than its equity
Elevance Health's debt has increased by 9% YoY
The debt to equity is up by 4.5% year-on-year but it has declined by 2.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.